Share on StockTwits

Astro-Med (NASDAQ:ALOT) major shareholder Of Albert W. Ondis Estate sold 9,991 shares of the stock on the open market in a transaction that occurred on Tuesday, June 24th. The shares were sold at an average price of $13.70, for a total transaction of $136,876.70. Following the completion of the sale, the insider now directly owns 1,440,542 shares in the company, valued at approximately $19,735,425. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Astro-Med (NASDAQ:ALOT) traded down 2.60% during mid-day trading on Thursday, hitting $13.50. The stock had a trading volume of 10,516 shares. Astro-Med has a 52-week low of $10.20 and a 52-week high of $14.83. The stock’s 50-day moving average is $13.54 and its 200-day moving average is $13.35. The company has a market cap of $103.7 million and a P/E ratio of 22.76.

Astro-Med (NASDAQ:ALOT) last issued its quarterly earnings data on Thursday, May 22nd. The company reported $0.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.07. The company had revenue of $20.80 million for the quarter, compared to the consensus estimate of $15.49 million.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, July 1st. Investors of record on Friday, June 13th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 2.02%. The ex-dividend date is Wednesday, June 11th.

Astro-Med, Inc (NASDAQ:ALOT) designs, develops, manufactures and distributes a range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate advanced technologies in order to acquire, store, analyze, and present data in multiple formats.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.